Delivery Order SPE2DR25D3012-SPE2DR26F4B7Y
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,742.16 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Teriparatide 560mcg/2.24mL pens. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet...
- The Defense Logistics Agency (DLA) awarded a $1,633.20 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Teriparatide 560mcg/2.24mL pen injections. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,758.48 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on November 4, 2025, with completion scheduled for November 5, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $4,171.60 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560MCG/2.24ML pens on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 6, 2025, for the supply of Teriparatide 560 mcg/2.24 mL pen injections, valued at $13,541.58. This firm fixed-price, competitively awarded contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. The delivery order carries no set-aside designation and represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,322.26 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on May 27, 2025. This competitively awarded, firm fixed-price delivery order is structured with an ultimate completion date of May 28, 2025, and carries no set-aside designation. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,569.17 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,172.66 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on October 28, 2025, with completion scheduled for October 29, 2025. The award utilized firm fixed price pricing with no set-aside designation, indicating the contract was competitively awarded. Performance will be executed from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,388.67 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on May 30, 2025, with completion scheduled for June 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,076.99 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed price, competitively awarded contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4B7YDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,502.63 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 MCG/2.24 ML pens on November 14, 2025. This firm fixed-price delivery order is set to be completed by November 17, 2025 and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement without set-aside designation, reflecting AmerisourceBergen's capability to compete for federal medical supply contracts. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. Teriparatide is a bone-building medication commonly used in federal healthcare programs to treat osteoporosis, and this delivery order represents one of many pharmaceutical product fulfillments the company executes under its expansive global pharmaceutical support vehicle serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/14/25 |